Clinical investigation of partially pure and recombinant DNA derived leukocyte interferon in human cancer.
D000230:Adenocarcinoma / Q000628:therapy; D000293:Adolescent; D000328:Adult; D000917:Antibody Formation; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000628:therapy; D004274:DNA, Recombinant; D005260:Female; D006801:Humans; D007223:Infant; D007370:Interferon Type I / Q000276:immunology / Q000302:isolation & purification / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy; D007822:Laryngeal Neoplasms / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D010212:Papilloma / Q000628:therapy; D011471:Prostatic Neoplasms / Q000628:therapy
D004274:DNA, Recombinant; D007370:Interferon Type I